1. 2870 Prospective evaluation of both plasma Epstein Barr Virus (EBV) DNA clearance and fludeoxyglucose-positron emission tomography (PET-CT) as a dual-endpoint in predicting early response and survival of patients undergoing chemotherapy (chemo) for advanced nasopharyngeal carcinoma (NPC) (NCT01365208). (September 2015) Authors: Ma, B.; Leung, S.F.; Hui, E.P.; King, A.D.; Wang, K.; Mo, F.; Li, L.; Loong, H.; Kam, M.; Chan, A.; Wong, S.C.C.; Chan, A.T.C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S580 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 30P Frequency of peripheral CD8+ T cells expressing chemo-attractant receptors increases in NPC patients with EBV clearance upon radiotherapy. (December 2022) Authors: Mahajan, S.; Oostvogels, A.; Balcioglu, E.; Lo, K.W.; Chan, A.; Hui, E.P.; Tsang, A.; Ma, B.B.Y.; Debets, R. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗